血清N-聚糖检测在评估1型糖尿病成人早期血管老化(动脉僵硬)中的应用
研究纳入84例病程超过10年且无心血管事件的1型糖尿病成人和68名健康对照,检测血清GlycA、GlycB及主动脉脉搏波速度。1型糖尿病患者的主动脉脉搏波速度与GlycA、GlycB浓度及峰高/峰宽比均高于健康对照,且这些指标与主动脉脉搏波速度相关,校正混杂因素后GlycA浓度及GlycA、GlycB的峰高/峰宽比仍与主动脉脉搏波速度独立相关。作者认为检测血清GlycA和GlycB可能有助于评估1型糖尿病成人的血管老化。
要点
- 1型糖尿病成人主动脉脉搏波速度中位数7.9 m/s,高于健康对照的6.1 m/s(P<0.001)。
- 1型糖尿病成人GlycA浓度中位数850.4 μmol/L,高于健康对照的652.4 μmol/L(P<0.001)。
- GlycA浓度及GlycA、GlycB峰高/峰宽比与主动脉脉搏波速度独立相关。
核心结论
- 检测血清GlycA和GlycB可能有助于评估病程超过10年且无心血管事件的1型糖尿病成人的血管老化。
研究设计与样本
- 研究纳入84例病程超过10年且无心血管事件的1型糖尿病成人和68名健康对照,评估临床特征、主动脉脉搏波速度及血清GlycA和GlycB。
主要发现
- 1型糖尿病患者主动脉脉搏波速度中位数7.9(6.9-9.1)m/s,高于健康对照的6.1(5.5-6.7)m/s(P<0.001)。
- 1型糖尿病患者GlycA浓度中位数850.4(781.3-916.1)μmol/L,高于健康对照的652.4(581.5-727.1)μmol/L(P<0.001)。
- 1型糖尿病患者GlycB浓度中位数386.1(353.2-426.3)μmol/L,高于健康对照的310.0(280.5-331.9)μmol/L(P<0.001)。
- 1型糖尿病患者GlycA峰高/峰宽比中位数16.5(14.9-18.1),高于健康对照的15.0(13.7-16.7);GlycB峰高/峰宽比中位数5.0(4.6-5.5),高于健康对照的4.0(3.4-4.3)(P<0.001)。
- 主动脉脉搏波速度与GlycA浓度(r=0.550)、GlycB浓度(r=0.423)、GlycA峰高/峰宽比(r=0.453)及GlycB峰高/峰宽比(r=0.510)相关(P<0.001)。
关键数值与推荐
- 校正潜在混杂因素后,GlycA浓度(β=0.212,P<0.001)、GlycA峰高/峰宽比(β=0.150,P=0.009)和GlycB峰高/峰宽比(β=0.155,P=0.011)仍与主动脉脉搏波速度独立相关。
- 检测主动脉脉搏波速度>10 m/s个体的C统计量:GlycA水平为0.866(95%CI 0.794-0.937),GlycB峰高/峰宽比为0.862(95%CI 0.780-0.943)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Vascular aging (arterial stiffness [AS]) is an inflammation-linked process that predicts macro- and microvascular complications in adults with type 1 diabetes (T1D). We evaluated the utility of measuring the inflammation-linked N-glycans GlycA and GlycB to assess vascular aging in adults with T1D. RESEARCH DESIGN AND METHODS: Eighty-four adults with T1D (>10-year duration without cardiovascular events) and 68 healthy control subjects were evaluated for clinical characteristics (including microvascular complications in patients with T1D), aortic pulse wave velocity (aPWV) (surrogate measure of AS), and serum GlycA and GlycB (peak area [concentration] and height/width [H/W] ratio) using 1H-nuclear magnetic resonance spectroscopy. RESULTS: Patients with T1D had higher median (interquartile range) values than healthy control subjects for (P < 0.001 for all comparisons) aPWV 7.9 (6.9-9.1) vs. 6.1 (5.5-6.7) m/s, GlycA 850.4 (781.3-916.1) vs. 652.4 (581.5-727.1) μmoL; GlycB 386.1 (353.2-426.3) vs. 310.0 (280.5-331.9) μmol/L), H/W ratio of GlycA 16.5 (14.9-18.1) vs. 15.0 (13.7-16.7), and H/W ratio of GlycB 5.0 (4.6-5.5) vs. 4.0 (3.4-4.3). Moreover, aPWV correlated (P < 0.001 for all correlations) with GlycA (r = 0.550) and GlycB (r = 0.423) concentrations and with H/W ratios of GlycA (r = 0.453) and GlycB (r = 0.510). Adjusting for potential confounders, GlycA concentration (β = 0.212, P < 0.001) and the H/W ratios of GlycA (β = 0.150, P = 0.009) and GlycB (β = 0.155, P = 0.011) remained independently associated with aPWV. C-statistics for detecting individuals with aPWV >10 m/s were 0.866 (95% CI 0.794-0.937) for GlycA levels and 0.862 (0.780-0.943) for H/W ratio of GlycB. CONCLUSIONS: Measurement of serum GlycA and GlycB may have utility in assessing vascular aging in adults with T1D of >10-year duration and no previous cardiovascular events.
引用
- Llauradó G, Amigó N, Fuertes-Martín R, et al. Measurement of Serum N-Glycans in the Assessment of Early Vascular Aging (Arterial Stiffness) in Adults With Type 1 Diabetes. Diabetes Care. 2022. PMID: 35984043. doi:10.2337/dc22-0331
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。